Depression

Citations 11-15 of 15 total displayed.

Past content (since Nov 1998):

Original Contributions
Depression as a Risk Factor for Alzheimer Disease: The MIRAGE Study

Robert C. Green; L. Adrienne Cupples; Alex Kurz; Sanford Auerbach; Rodney Go; Dessa Sadovnick; Ranjan Duara; Walter A. Kukull; Helena Chui; Timi Edeki; Patrick A. Griffith; Robert P. Friedland; David Bachman; Lindsay Farrer
Arch Neurol 2003; 60: 753-759. [Abstract] [Full text] [PDF]  

Original Contributions
Treatment of Depression Is Associated With Suppression of Nonspecific and Antigen-Specific T_H1 Responses in Multiple Sclerosis

David C. Mohr; Donald E. Goodkin; Janeen Islar; Stephen L. Hauser; Claude P. Genain
Arch Neurol 2001; 58: 1081-1086. [Abstract] [Full text] [PDF]  

Original Contributions
Factors Associated With Incident Human Immunodeficiency Virus–Dementia

Yaakov Stern; Michael P. McDermott; Steven Albert; Donna Palumbo; Ola A. Selnes; Justin McArthur; Ned Sacktor; Giovanni Schifitto; Karl Kieburtz; Leon Epstein; Karen S. Marder; for the Dana Consortium on the Therapy of HIV–Dementia and Related Cognitive Disorders
Arch Neurol 2001; 58: 473-479. [Abstract] [Full text] [PDF]  

Original Contributions
Course of Depression During the Initiation of Interferon Beta-1a Treatment for Multiple Sclerosis

David C. Mohr; William Likosky; Pat Dwyer; Judy Van Der Wende; Arne C. Boudewyn; Donald E. Goodkin
Arch Neurol 1999; 56: 1263-1265. [Abstract] [Full text] [PDF]  

Special Articles
Clinical Research Designs for Emerging Treatments for Alzheimer Disease: Moving Beyond Placebo-Controlled Trials

David Knopman; Jeffrey Kahn; Steven Miles
Arch Neurol 1998; 55: 1425-1429. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   Pages: 1 2